Lexicon Pharmaceuticals Inc (LXRX) — Capital Reinvestment Ratio
Lexicon Pharmaceuticals Inc (LXRX) has a Capital Reinvestment Ratio of 0.00x as of September 2019, meaning it reinvests 0% of its operating cash flow ($190.70 Million) in capital expenditures ($70.00K). See Lexicon Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lexicon Pharmaceuticals Inc Capital Reinvestment Ratio (2005–2019)
This chart tracks Lexicon Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Check LXRX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Lexicon Pharmaceuticals Inc (2005–2019)
Year-by-year Capital Reinvestment Ratio for Lexicon Pharmaceuticals Inc from 2005 to 2019. For live market cap and broader valuation context, see how much is Lexicon Pharmaceuticals Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $113.81 Million | $70.00K | ▼ -87.5% |
| 2015 | 0.00x | $184.78 Million | $910.00K | ▼ -99.0% |
| 2005 | 0.48x | $23.44 Million | $11.28 Million | — |